Literature DB >> 35199048

Ibuprofen inhibits key genes involved in androgen production in theca-interstitial cells.

Chelsea W Fox1, Lingzhi Zhang2, Benjamin C Moeller3, V Gabriel Garzo4, R Jeffrey Chang2, Antoni J Duleba2.   

Abstract

OBJECTIVE: To study the effects of ibuprofen on androgen production, gene expression, and cell viability in rat theca-interstitial cells exposed to the proinflammatory stimuli interleukin-1β (IL-1β) and lipopolysaccharide (LPS).
DESIGN: Animal study.
SETTING: University-based research laboratory. PATIENTS/ANIMALS: Theca-interstitial cells were isolated from 30 day old female Sprague Dawley rats.
INTERVENTIONS: Theca cells were cultured with pro-inflammatory media containing IL-1β and LPS and compared with cells cultured in control media. MAIN OUTCOME MEASURES: Androstenedione quantification was performed on conditioned cell culture medium using liquid chromatography-mass spectrometry. Theca cell viability was assessed using PrestoBlue cell viability assay. The gene expression of Cyp17a1, Cyp11a1, and Hsd3b was analyzed using quantitative polymerase chain reaction.
RESULTS: Both proinflammatory stimuli IL-1β and LPS increased androstenedione concentration in cell culture medium, and these effects were mitigated with ibuprofen. Both inflammatory agents in addition increased the expression of key genes involved in androgen synthesis: Cyp17a1, Cyp11a1, and Hsd3b; the addition of ibuprofen to the culture medium inhibited these effects. Theca cell viability increased with IL-1β and LPS. Ibuprofen inhibited the IL-1β-mediated increase in cell viability but did not reverse the effects of LPS.
CONCLUSIONS: In conclusion, our findings support the hypothesis that many of the alterations induced by inflammatory stimuli in theca-interstitial cells are abrogated by the addition of ibuprofen.

Entities:  

Keywords:  Androgen excess; inflammation; polycystic ovary syndrome

Mesh:

Substances:

Year:  2021        PMID: 35199048      PMCID: PMC8862173          DOI: 10.1016/j.xfss.2021.06.004

Source DB:  PubMed          Journal:  F S Sci        ISSN: 2666-335X


  33 in total

Review 1.  Androgen excess is the key element in polycystic ovary syndrome.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2003-08       Impact factor: 7.329

2.  Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome.

Authors:  F Gonzalez; K Thusu; E Abdel-Rahman; A Prabhala; M Tomani; P Dandona
Journal:  Metabolism       Date:  1999-04       Impact factor: 8.694

Review 3.  Inflammasomes: mechanism of action, role in disease, and therapeutics.

Authors:  Haitao Guo; Justin B Callaway; Jenny P-Y Ting
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

Review 4.  Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway.

Authors:  Diane M Duffy
Journal:  Hum Reprod Update       Date:  2015-05-29       Impact factor: 15.610

5.  Inflammatory Stimuli Trigger Increased Androgen Production and Shifts in Gene Expression in Theca-Interstitial Cells.

Authors:  Chelsea W Fox; Lingzhi Zhang; Abhishek Sohni; Manuel Doblado; Miles F Wilkinson; R Jeffrey Chang; Antoni J Duleba
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736

6.  Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial.

Authors:  Antoni J Duleba; Beata Banaszewska; Robert Z Spaczynski; Leszek Pawelczyk
Journal:  Fertil Steril       Date:  2006-03-09       Impact factor: 7.329

7.  Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial.

Authors:  Beata Banaszewska; Joanna Wrotyńska-Barczyńska; Robert Z Spaczynski; Leszek Pawelczyk; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2016-10-18       Impact factor: 5.958

Review 8.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

9.  Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis.

Authors:  Israel Ortega; Jesus A Villanueva; Donna H Wong; Amanda B Cress; Anna Sokalska; Scott D Stanley; Antoni J Duleba
Journal:  J Ovarian Res       Date:  2014-02-13       Impact factor: 4.234

10.  Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Zheng Peng; Yifan Sun; Xiaolan Lv; Hongyu Zhang; Chunming Liu; Shengming Dai
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more
  1 in total

1.  Ibuprofen Reduces Testosterone Level in Women With Polycystic Ovary Syndrome.

Authors:  Beata Banaszewska; Katarzyna Ozegowska; Martyna Polska; Leszek Pawelczyk; R Jeffrey Chang; Antoni J Duleba
Journal:  J Endocr Soc       Date:  2022-08-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.